Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02855645Phase 3Unknown
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by China Medical University Hospital. Primary endpoints: Glycated Hemoglobin A1c at 3 months and Plasma Blood Sugar at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02855645.